[go: up one dir, main page]

WO2008133196A1 - 再生医療用材料 - Google Patents

再生医療用材料 Download PDF

Info

Publication number
WO2008133196A1
WO2008133196A1 PCT/JP2008/057574 JP2008057574W WO2008133196A1 WO 2008133196 A1 WO2008133196 A1 WO 2008133196A1 JP 2008057574 W JP2008057574 W JP 2008057574W WO 2008133196 A1 WO2008133196 A1 WO 2008133196A1
Authority
WO
WIPO (PCT)
Prior art keywords
regenerative medicine
matrix
genetically modified
modified gelatin
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/057574
Other languages
English (en)
French (fr)
Inventor
Shouji Ooya
Takayuki Kobayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Corp
Original Assignee
Fujifilm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp filed Critical Fujifilm Corp
Publication of WO2008133196A1 publication Critical patent/WO2008133196A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/222—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

　本発明の目的は、コラーゲン様ペプチドの感染症リスクの低減と再生医療用のマトリックスに必要な各種パラメーターの精密な設計を可能にした再生医療用材料を提供することである。本発明によれば、遺伝子組み換えゼラチンをマトリックスとして生体組織に接触させて用いることを特徴とする再生医療用材料が提供される。
PCT/JP2008/057574 2007-04-19 2008-04-18 再生医療用材料 Ceased WO2008133196A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-110041 2007-04-19
JP2007110041 2007-04-19

Publications (1)

Publication Number Publication Date
WO2008133196A1 true WO2008133196A1 (ja) 2008-11-06

Family

ID=39925650

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/057574 Ceased WO2008133196A1 (ja) 2007-04-19 2008-04-18 再生医療用材料

Country Status (1)

Country Link
WO (1) WO2008133196A1 (ja)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010128672A1 (ja) * 2009-05-07 2010-11-11 富士フイルム株式会社 遺伝子組み換えゼラチンを含む血管新生誘導剤
WO2011027850A1 (ja) * 2009-09-04 2011-03-10 富士フイルム株式会社 ゼラチンを含む骨再生剤
JP2012219100A (ja) * 2011-04-12 2012-11-12 Fujifilm Corp 細胞と生体適合性高分子を含む組成物
CN102791301A (zh) * 2010-03-02 2012-11-21 富士胶片株式会社 细胞支持体和骨再生材料
JP2013074936A (ja) * 2011-09-29 2013-04-25 Fujifilm Corp 血管内皮細胞遊走用足場
JP2014012114A (ja) * 2011-08-31 2014-01-23 Fujifilm Corp 細胞移植用細胞構造体および細胞移植用細胞集合体
WO2014050908A1 (ja) 2012-09-26 2014-04-03 富士フイルム株式会社 ポリペプチド、足場組成物、軟骨組織修復用組成物、軟骨細胞培養用組成物及びグリコサミノグリカン産生促進用組成物
JP2016174538A (ja) * 2015-03-18 2016-10-06 富士フイルム株式会社 管状構造物、細胞構造体の製造方法、及び管状構造物の製造方法
CN111704663A (zh) * 2020-06-29 2020-09-25 江南大学 一种胶原蛋白水凝胶的制备方法
CN111793127A (zh) * 2020-06-17 2020-10-20 江南大学 一种iii型类人胶原蛋白及其编码基因、重组菌与应用
CN112661856A (zh) * 2020-08-20 2021-04-16 点斗基因科技(南京)有限公司 一种elp类胶原蛋白的纯化方法及应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03502935A (ja) * 1988-11-09 1991-07-04 プロテイン　ポリマー　テクノロジーズ，インコーポレイティド 組換え的に調製された官能的な合成タンパク質ポリマー
JP2001502548A (ja) * 1996-10-29 2001-02-27 コモンウェルス サイエンティフィック アンド アンダストリアル リサーチ オーガニゼーション 三重らせんタンパク質の安定発現
JP2003516730A (ja) * 1999-11-12 2003-05-20 ファイブローゲン、インコーポレーテッド 組換えゼラチン
WO2004085473A2 (en) * 2003-03-28 2004-10-07 Fuji Photo Film B.V. Rgd-enriched gelatine-like proteins with enhanced cell binding
JP2007277217A (ja) * 2006-03-17 2007-10-25 Fujifilm Corp 薬剤を均一に封入した生分解性マトリックス

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03502935A (ja) * 1988-11-09 1991-07-04 プロテイン　ポリマー　テクノロジーズ，インコーポレイティド 組換え的に調製された官能的な合成タンパク質ポリマー
JP2001502548A (ja) * 1996-10-29 2001-02-27 コモンウェルス サイエンティフィック アンド アンダストリアル リサーチ オーガニゼーション 三重らせんタンパク質の安定発現
JP2003516730A (ja) * 1999-11-12 2003-05-20 ファイブローゲン、インコーポレーテッド 組換えゼラチン
WO2004085473A2 (en) * 2003-03-28 2004-10-07 Fuji Photo Film B.V. Rgd-enriched gelatine-like proteins with enhanced cell binding
JP2007277217A (ja) * 2006-03-17 2007-10-25 Fujifilm Corp 薬剤を均一に封入した生分解性マトリックス

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5752033B2 (ja) * 2009-05-07 2015-07-22 富士フイルム株式会社 遺伝子組み換えゼラチンを含む血管新生誘導剤
WO2010128672A1 (ja) * 2009-05-07 2010-11-11 富士フイルム株式会社 遺伝子組み換えゼラチンを含む血管新生誘導剤
US9968661B2 (en) 2009-09-04 2018-05-15 Fujifilm Corporation Bone regeneration agent including gelatin
WO2011027850A1 (ja) * 2009-09-04 2011-03-10 富士フイルム株式会社 ゼラチンを含む骨再生剤
CN102625717A (zh) * 2009-09-04 2012-08-01 富士胶片株式会社 包含明胶的骨再生剂
US8987204B2 (en) 2009-09-04 2015-03-24 Fujifilm Coporation Bone regeneration agent comprising gelatin
CN102625717B (zh) * 2009-09-04 2016-03-16 富士胶片株式会社 包含明胶的骨再生剂
JP2015033635A (ja) * 2009-09-04 2015-02-19 富士フイルム株式会社 遺伝子組み換えゼラチンを含む肉芽組織形成剤
JP5642685B2 (ja) * 2009-09-04 2014-12-17 富士フイルム株式会社 ゼラチンを含む骨再生剤
US9101686B2 (en) 2010-03-02 2015-08-11 Fujifilm Corporation Cell support and bone regeneration material
CN102791301A (zh) * 2010-03-02 2012-11-21 富士胶片株式会社 细胞支持体和骨再生材料
JP2012219100A (ja) * 2011-04-12 2012-11-12 Fujifilm Corp 細胞と生体適合性高分子を含む組成物
JP2016188235A (ja) * 2011-04-12 2016-11-04 富士フイルム株式会社 細胞と生体適合性高分子を含む組成物
US10406183B2 (en) 2011-04-12 2019-09-10 Fujifilm Corporation Composition comprising cell and biocompatible polymer
JP2014012114A (ja) * 2011-08-31 2014-01-23 Fujifilm Corp 細胞移植用細胞構造体および細胞移植用細胞集合体
JP2013074936A (ja) * 2011-09-29 2013-04-25 Fujifilm Corp 血管内皮細胞遊走用足場
EP2578246A3 (en) * 2011-09-29 2015-01-14 Fujifilm Corporation Scaffold for vascular endothelial cell migration
US9932557B2 (en) 2012-09-26 2018-04-03 Fujifilm Corporation Polypeptide, scaffold composition, composition for cartilage tissue restoration, composition for cartilage cell culture, and composition for promoting glycosaminoglycan production
WO2014050908A1 (ja) 2012-09-26 2014-04-03 富士フイルム株式会社 ポリペプチド、足場組成物、軟骨組織修復用組成物、軟骨細胞培養用組成物及びグリコサミノグリカン産生促進用組成物
JP2016174538A (ja) * 2015-03-18 2016-10-06 富士フイルム株式会社 管状構造物、細胞構造体の製造方法、及び管状構造物の製造方法
CN111793127A (zh) * 2020-06-17 2020-10-20 江南大学 一种iii型类人胶原蛋白及其编码基因、重组菌与应用
CN111793127B (zh) * 2020-06-17 2021-11-02 江南大学 一种iii型类人胶原蛋白及其编码基因、重组菌与应用
CN111704663A (zh) * 2020-06-29 2020-09-25 江南大学 一种胶原蛋白水凝胶的制备方法
CN112661856A (zh) * 2020-08-20 2021-04-16 点斗基因科技(南京)有限公司 一种elp类胶原蛋白的纯化方法及应用

Similar Documents

Publication Publication Date Title
WO2008133196A1 (ja) 再生医療用材料
ES2422739T3 (es) Composición para el diagnóstico, prevención o tratamiento de enfermedades relacionadas con células que expresan IL-8 o GRO-, que comprende MSC de UCB
EP2102927A4 (en) CORE SHELL SPINEL CATHODE ACTIVE MATERIALS FOR LITHIUM SECONDARY BATTERIES, THOSE USING LITHIUM SECONDARY BATTERIES AND METHOD OF MANUFACTURING THEREOF
NZ593364A (en) Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
WO2008103041A8 (en) Recombinant gelatins
WO2010008739A3 (en) Aryl gpr119 agonists and uses thereof
UA108598C2 (xx) Високоефективні кон'югати та гідрофільні зшиваючі агенти (лінкери)
SG196838A1 (en) Gpr120 receptor agonists and uses thereof
FR2903702B1 (fr) Equivalent d'epiderme capable de se pigmenter obtenu a partir de cellules de la matrice, procede de preparation et utilisation
MX2008014679A (es) Ensayos para diagnosticar y evaluar opciones de tratamiento para enfermedad de fabry.
HUE058891T2 (hu) Módszer és készítmények a T-sejtek fokozott tumorellenes effektor mûködésének fokozására
CL2012002416A1 (es) Proteina de union capaz de unirse a dll4; construccion de anticuerpo que comprende dicha proteina; conjugado de anticuerpo; acido nucleico, vector y celula huesped que comprenden el anticuerpo; composicion para la liberacion de una proteina de union; metodo para reducir la actividad del dll4 humano.
AR077333A1 (es) Anticuerpos humanos de alta afinidad para la angiopoyetina -2 humana
WO2010048207A3 (en) Aryl gpr120 receptor agonists and uses thereof
BRPI0819649A2 (pt) método, organismo geneticamente modificado, e, célula de levedura recinbinante
NZ593365A (en) Pharmaceutical preparation comprising a blood mononuclear cell culture
EP2215262A4 (en) GLYCEMIC CONTROL TO REDUCE THE RISK OF A HEART CIRCULATION DISEASE IN DIABETICS WITH HAPTOGLOBIN 2-2 EXPRESSION
WO2010073152A3 (en) Single use sterilization container
WO2009114712A3 (en) Assays for diagnosing and evaluating treatment options for pompe disease
WO2013056049A3 (en) Tubular prostheses
WO2012050896A3 (en) Protease selective supramolecular assemblies
WO2007109733A3 (en) Diagnostic and prognostic markers and treatment strategies for multiple sclerosis
WO2006104866A3 (en) Controlled adhesion glove
NZ601735A (en) Antibody with binding specificity for Nedd4 protein for reducing influenza infectivity
IL203762A (en) Use of collagen-containing preparation for biological cell growth

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08740629

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08740629

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP